Latest research report on “Therapeutic Nuclear Medicines Market” now available at high quality database of ReportsnReports.com with market size, share, trends, competitive and statistical analysis. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample Copy @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5554500
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
This report contains market size and forecasts of Therapeutic Nuclear Medicines in global, including the following market information:
Global Therapeutic Nuclear Medicines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Therapeutic Nuclear Medicines Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Therapeutic Nuclear Medicines companies in 2021 (%)
The global Therapeutic Nuclear Medicines market was valued at 1719.4 million in 2021 and is projected to reach US$ 5230.4 million by 2028, at a CAGR of 17.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Radium-223 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Therapeutic Nuclear Medicines include Novartis AG, Bayer, China Isotope & Radiation, Q BioMed, Curium Pharmaceuticals, Jubilant DraxImage, Dongcheng, Lantheus and Acrotech Biopharma., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Therapeutic Nuclear Medicines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Therapeutic Nuclear Medicines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Therapeutic Nuclear Medicines Market Segment Percentages, by Type, 2021 (%)
– Radium-223
– Lutetium-177
– Iodine-131
– Other
Global Therapeutic Nuclear Medicines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Therapeutic Nuclear Medicines Market Segment Percentages, by Application, 2021 (%)
– Thyroid
– Bone Metastasis
– Lymphoma
– Other
Global Therapeutic Nuclear Medicines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Therapeutic Nuclear Medicines Market Segment Percentages, By Region and Country, 2021 (%)
– North America
– – US
– – Canada
– – Mexico
– Europe
– – Germany
– – France
– – U.K.
– – Italy
– – Russia
– – Nordic Countries
– – Benelux
– – Rest of Europe
– Asia
– – China
– – Japan
– – South Korea
– – Southeast Asia
– – India
– – Rest of Asia
– South America
– – Brazil
– – Argentina
– – Rest of South America
– Middle East & Africa
– – Turkey
– – Israel
– – Saudi Arabia
– – UAE
– – Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Therapeutic Nuclear Medicines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Therapeutic Nuclear Medicines revenues share in global market, 2021 (%)
Key companies Therapeutic Nuclear Medicines sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Therapeutic Nuclear Medicines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
– Novartis AG
– Bayer
– China Isotope & Radiation
– Q BioMed
– Curium Pharmaceuticals
– Jubilant DraxImage
– Dongcheng
– Lantheus
– Acrotech Biopharma.
– Progenics Pharmaceuticals
– International Isotopes
More information about Discount offers (25% or More) @ https://www.reportsnreports.com/contacts/discount.aspx?name=5554500
About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
We provide 24/7 online and offline support to our customers.
E-mail: [email protected]
Phone: +1 888 391 5441